Agios Pharmaceuticals (AGIO) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q3 2025 value amounting to $74.8 million.
- Agios Pharmaceuticals' Total Current Liabilities fell 3741.62% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.8 million, marking a year-over-year decrease of 3741.62%. This contributed to the annual value of $81.2 million for FY2024, which is 1942.61% up from last year.
- Per Agios Pharmaceuticals' latest filing, its Total Current Liabilities stood at $74.8 million for Q3 2025, which was down 3741.62% from $70.4 million recorded in Q2 2025.
- Agios Pharmaceuticals' 5-year Total Current Liabilities high stood at $119.5 million for Q3 2024, and its period low was $45.1 million during Q1 2023.
- In the last 5 years, Agios Pharmaceuticals' Total Current Liabilities had a median value of $59.8 million in 2021 and averaged $64.4 million.
- Per our database at Business Quant, Agios Pharmaceuticals' Total Current Liabilities tumbled by 5254.91% in 2022 and then soared by 10445.19% in 2024.
- Agios Pharmaceuticals' Total Current Liabilities (Quarter) stood at $59.8 million in 2021, then grew by 4.69% to $62.6 million in 2022, then increased by 8.5% to $68.0 million in 2023, then grew by 19.43% to $81.2 million in 2024, then dropped by 7.88% to $74.8 million in 2025.
- Its last three reported values are $74.8 million in Q3 2025, $70.4 million for Q2 2025, and $52.4 million during Q1 2025.